Medtronic plc — Director's Dealing 2017

Mar 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2017-03-20

Reporting Person: TEN HOEDT ROB (EVP & President EMEA)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-20	Ordinary Shares	M	8154	$37.53	Acquired	59392	Direct
2017-03-20	Ordinary Shares	M	21129	$38.81	Acquired	80521	Direct
2017-03-20	Ordinary Shares	M	10357	$62.76	Acquired	90878	Direct
2017-03-20	Ordinary Shares	M	11117	$55.32	Acquired	101995	Direct
2017-03-20	Ordinary Shares	S	50757	$81.5768	Disposed	51238	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-20	Stock Option (Right to Buy)	$37.53	M	8154	Disposed	2020-08-02	Ordinary Shares (8154)	Direct
2017-03-20	Stock Option (Right to Buy)	$38.81	M	21129	Disposed	2022-07-30	Ordinary Shares (21129)	Direct
2017-03-20	Stock Option (Right to Buy)	$62.76	M	10357	Disposed	2024-07-28	Ordinary Shares (10357)	Direct
2017-03-20	Stock Option (Right to Buy)	$55.32	M	11117	Disposed	2023-07-29	Ordinary Shares (11117)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.301 to $82.098, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: This balance increased by 386 shares due to exempt transactions such as dividend reinvestment.

F3: This option to purchase 8,154 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 8,154 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F4: This option to purchase 21,129 New Medtronic ordinary shares for $38.81per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 21,129 Medtronic common stock shares for $38.81per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F5: This option to purchase 20,714 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 20,714 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F6: This option to purchase 14,823 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 14,823 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.